CEACAM5 and gastric cancer: The commonly used biomarkers for screening and monitoring gastric cancer, such as carcinoembryonic antigen (CEA) or carbohydrate antigens CA19-9 and CA72-4, have limited sensitivity and specificity and are not effective in detecting premalignant lesions.